| abstract |
The invention relates to a process for the production of pharmaceutical forms or precursors thereof by means of extrusion, the pharmaceutical form having a matrix essentially containing the active substance content, the essential properties of which are formed by extrusion, and a polysaccharide and / or a derivative thereof and / or a complex thereof and / or any mixture of the aforementioned substances with other substances and / or saccharides and / or derivatives thereof as an essential component of the matrix and at least one pharmaceutically active substance. The invention further relates to a pharmaceutical form which contains a matrix essentially containing the active substance content, the essential properties of which are formed by extrusion, and a polysaccharide and / or derivative thereof and / or a complex thereof and / or any mixture of the aforementioned substances other substances and / or saccharides and / or derivatives thereof as an essential component of the matrix and at least one pharmaceutically active substance. The invention further relates to the use of the pharmaceutical form for the production of granules for tableting and capsule filling, for further processing by injection molding, as an auxiliary in direct tableting and / or for the production of monoblock pharmaceutical forms. |